May

Blog Posts in May, 2014

Blog Home
  • Crab Meat Recalled For Listeria

    Posted By Golomb & Honik || 31-May-2014

    A voluntary recall was issued for minced crab meat packaged by Rome Packing Co., based in East Providence, Rhode Island. During a routine sampling, the company discovered that some of the products may have been contaminated with Listeria. The products are distributed nationwide and the company is encouraging any patrons that purchased these products to return them to the store they purchased them ...
    Continue Reading
  • Ford Recalls Over 1 Million Cars

    Posted By Golomb & Honik || 30-May-2014

    Ford has issued recalls for almost 1.4 million cars in order to fix steering issues and other problems. Over 900,000 of the recalls were to address a torque sensor that could malfunction within the steering column. This malfunction could cause the electronic steering assistance to fail. In addition to that recall, nearly 200,000 vehicles were recalled for a problem with the intermittent electrical ...
    Continue Reading
  • $650 Million Settlement Over Blood Thinners

    Posted By Golomb & Honik || 30-May-2014

    In a recent development, the German drug company, Boehringer Ingelheim, has agreed to pay $650 million to settle the thousands of lawsuits against it for the blood thinner, Pradaxa. Pradaxa functions as a blood thinner, but the lawsuits claim that its power could be overwhelming at times, sometimes causing fatal bleeding. Emergency workers even claimed that the bleeding didn’t respond to ...
    Continue Reading
  • GM Recalls Continuing Into Summer

    Posted By Golomb & Honik || 29-May-2014

    After delaying the recall of 2.6 million vehicles, General Motors has already paid a $35 million dollar settlement to the U.S. Transportation Department. That recall was over faulty ignition switches that have caused 13 reported deaths so far. In addition to the faulty ignition recalls, several other recalls have been issued by GM for issues with airbags, fire hazards, shifter cables, and faulty ...
    Continue Reading
  • FDA says Testosterone Treatment must include Blood Clot Warning

    Posted By Golomb & Honik || 27-May-2014

    The experienced attorneys at Golomb & Honik represent defective drug cases aggressively. If you have been injured by a defective, dangerous drug, then you deserve compensation. Last week, the US Food and Drug Administration told the manufacturers of testosterone treatments that they must properly warn of the risk of blood clots. Blood clots that form in the veins can be life-threatening if ...
    Continue Reading
  • CFPB Takes Action Against Deceptive "Free Checking" Ads

    Posted By Golomb & Honik || 22-May-2014

    In October, the Consumer Financial Protection Bureau (CFBP) took action against M&T Bank for misleading advertisements of free checking accounts. The Bureau found that M&T had acted unethically by failing to inform customers of integral account qualifications while enticing them with promises of free "no strings attached" checking. In actuality, the accounts were free as long as ...
    Continue Reading
  • Johnson & Johnson Suspends Morcellator Sales After Concerns of Cancer Raised

    Posted By Golomb & Honik || 14-May-2014

    Philadelphia, Pennsylvania, New Jersey, Nationwide Johnson & Johnson has suspended worldwide sales, distribution, and promotion of their laparoscopic power morcellators this past month. This suspension comes after the FDA warned physicians and J&J that the device could be spreading deadly uterine cancer when used during hysterectomies and fibroid removal surgery. Researchers show that ...
    Continue Reading
  • Injury Lawsuits Expose Health and Safety Hazards

    Posted By Golomb & Honik, P.C. || 14-May-2014

    Philadelphia, Pennsylvania, New Jersey, Nationwide While federal regulation and legislation aims to protect consumers from dangerous product defects, it is our legal system that is often responsible for exposing the safety hazards that manufacturers conceal. Product injury litigation shines a bright light on manufacturers and corporations whose dangerous drugs, medical devices, automobiles, and ...
    Continue Reading
  • Banks Aren't Any Better These Days

    Posted By Golomb & Honik || 14-May-2014

    A new study of checking account practices found that banks are still employing shady practices that hurt consumers, even after all the negative publicity in recent years. Half of big banks continue to reorder consumer transactions, leading to a hefty profit for banks each and every year. In fact, reordering checks cost consumers $32 billion a year, according to the Consumer Financial Protection ...
    Continue Reading
  • Snapchat Comes Clean, Settles with FTC

    Posted By Golomb & Honik, P.C. || 13-May-2014

    Philadelphia, Pennsylvania, New Jersey, Nationwide Snapchat recently came clean and agreed to settle charges with the Federal Trade Commission regarding claims that they made misrepresentations to consumers that violated users’ privacy and security. The allegations were centered on Snapchat’s video and photo feature. According to Snapchat, users could send images and videos that would ...
    Continue Reading
  • Drug Abuse by Healthcare Professionals Puts Patients at Risk

    Posted By Golomb & Honik || 8-May-2014

    The prescription drug epidemic in our country reaches deep into the medical community. More than 100,000 doctors, nurses, and other healthcare workers across America struggle with addiction to narcotics, such as oxycodone and fentanyl. Their problems are especially difficult to detect due to the knowledge and access these professionals have to narcotics and other prescription drugs on a regular ...
    Continue Reading
  • Deceptive Warning Labels at Root of New Lipitor Lawsuits

    Posted By Golomb & Honik || 1-May-2014

    New lawsuits against Pfizer continue to pour in claiming that their blockbuster statin drug, Lipitor, caused type 2 diabetes. When Lipitor was first approved in 1996, it was heralded as a breakthrough in controlling and reducing high levels of cholesterol. The drug works by preventing the creation of cholesterol in the body, which in turn lowers the prominence of LDL, the “bad ...
    Continue Reading
  • 12 results found. Viewing page 1 of 1.